Midgard Science

Eviogen Discovery Private Limited

Bengaluru, India eviogen.com From their website, Nov 2026

Work here? Claim this listing

About

Eviogen Discovery Private Limited is a contract research organization in Bangalore, India. It provides integrated drug discovery, biology, chemistry, DMPK, antibody, cell line, and protein services for pharma, biotech, life-science, and research organizations. It supports projects from target discovery and validation through lead selection and pre-clinical to clinical stages.

Services

  • Discovery biology

    Integrated drug discovery and screening support including target identification, target validation, in-vitro and in-vivo model development, ADMET, pharmacology, toxicology, and protein expression/purification.

    Assays & in vitro testing

  • Assay biology (in vitro)

    Cell-free and cell-based assay services against different therapeutic target classes for target validation and mechanism studies.

    Assays & in vitro testing

  • DMPK

    In vitro ADME and DMPK services including metabolism, permeability, transporters, solubility, physicochemical properties, protein binding, PK, and bioanalysis.

    ADME, DMPK & toxicology

  • In vitro ADMET

    Screening assays covering solution properties, drug absorption and transport, metabolic stability and identification, drug-drug interactions, and in vitro toxicity.

    ADME, DMPK & toxicology

  • Custom antibody development

    Polyclonal and monoclonal antibody development, purification, labeling, and single B-cell cloning and lead antibody identification.

    Assays & in vitro testing

  • Clone development and stable cell line generation

    Mammalian clone development and stable cell line generation for recombinant proteins, biosimilars, and novel biologics, including characterization and scale-up.

  • Discovery chemistry

    Integrated chemistry, biology, and analytical support for compound design, synthesis, testing, PROTAC chemistry, SAR generation, and lead optimization.

  • Integrated drug discovery services

    Provides integrated drug discovery support from target discovery to lead candidate selection, with flexible FFS or FTE business models.

14 more services
  • Assay biology
  • Small molecule discovery
  • PROTAC discovery
  • Screening services
  • Biologics services
  • PK & immunogenicity
  • CAR-T & iPSC services
  • CRISPR-Cas9 services
  • Antibody drug conjugate services
  • SPR analysis
  • Antibody hybridoma services
  • Sequencing services
  • Protein expression and purification
  • Cosmetic claim studies
Turnaround
3 weeks to 10 weeks
What to send
  • Polyclonal antibody development: minimum 5 mg of antigen at ≥0.5 mg/mL concentration
  • Antigen affinity chromatography requires antigen

Capabilities

Assays and studies
  • In vivo
  • Antibodies
  • ADME
  • SPR
  • ADCs
  • Cell therapy
23 more
  • High-content imaging
  • CRISPR
  • Hybridoma
  • Immunogenicity
  • Cell-free assays
  • Cell-based assays
  • Target validation
  • Mechanism studies
  • In vitro metabolism
  • In vitro permeability
  • Transporter assays
  • Solubility
  • Physicochemical properties
  • Protein binding
  • Bioanalysis
  • PK/PD
  • Enzyme inhibition
  • CYP induction
  • Luminescence
  • TR-FRET/HTRF
  • Fluorescence polarization
  • Absorbance
  • AlphaLISA
Scale and capacity
  • Cryopreservation of up to 20 clones per month
  • Scaled antibody production (50-100 mL)
  • From shake flasks to 2,000L bioreactors
  • Target Gene to Master Cell Bank in 6 months
  • DNA to production clone under 30 weeks
Therapeutic areas
  • Inflammation
  • Oncology
  • Immuno-oncology
  • Metabolic diseases
  • Fibrosis
  • Autoimmune disorder
  • Infection

Instruments and platforms

  • SPR (Biacore)
  • WES Protein Simple
  • AlphaLISA
  • AlphaScreen
  • TR-FRET
  • HTRF
5 more
  • NanoBRET
  • High Content Imaging
  • Flow Cytometry
  • Next Generation Sequencing
  • Biacore

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
  • Peptide
  • Cell therapy
  • Gene editing
  • Recombinant protein
  • Biosimilar
Species and models
  • Rabbit
  • Chicken
  • Mouse
  • CHO
  • HEK293
  • PBMCs
9 more
  • Patient derived primary cells
  • iPSCs
  • Immortalized primary cell line
  • Reporter cell lines
  • Recombinant protein
  • Transient/stable cell line
  • Mammalian cell lines
  • Animal/human PBMCs
  • Immune cells isolated from PBMCs

Industries served

  • Pharma
  • Biotech
  • Life-science
  • Research organizations
  • Biopharma
  • Pharmaceutical

Company

Type
CRO
Founded
2016
Quality
CPCSEA (animal procedures for monoclonal antibody production) · WHO (documentation aligned with cell line generation) · ICH (documentation aligned with cell line generation) · CDSCO (documentation aligned with cell line generation)

Locations

Based in
Bengaluru, India
Sites
Bangalore, India
Serves
Global

Contacts

Similar labs